TransCode Therapeutics (RNAZ)
(Delayed Data from NSDQ)
$1.78 USD
+0.14 (8.23%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.78 +0.01 (0.28%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/3/24 |
---|---|
Current Quarter | -0.70 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.98 |
Next Year | -0.67 |
EPS (TTM) | -774.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.70 | -0.58 | -1.98 | -0.67 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.70 | -0.58 | -1.98 | NA |
High Estimate | -0.70 | -0.58 | -1.98 | -0.67 |
Low Estimate | -0.70 | -0.58 | -1.98 | -0.67 |
Year ago EPS | -264.00 | -131.60 | -103.61 | -1.98 |
Year over Year Growth Est. | 99.73% | 99.56% | 98.09% | 66.16% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.70 | -0.58 | -1.98 | -0.67 |
7 Days Ago | -0.70 | -0.58 | -1.98 | -0.67 |
30 Days Ago | -0.70 | -0.50 | -2.14 | -0.67 |
60 Days Ago | NA | NA | -25.20 | -22.00 |
90 Days Ago | NA | NA | -25.20 | -22.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.70 | -0.58 | -1.98 | -0.67 |
Zacks Consensus Estimate | -0.70 | -0.58 | -1.98 | -0.67 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -67.20 | -131.60 | -264.00 | NA |
Estimate | NA | -60.00 | -135.60 | NA | NA |
Difference | NA | -7.20 | 4.00 | NA | -1.60 |
Surprise | NA | -12.00% | 2.95% | NA | -4.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more